Table_S1_28Aug2019 – Supplemental material for Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combinations in COPD

Siddiqui, Mohd Kashif; Shukla, Pragya; Jenkins, Martin; Ouwens, Mario; Guranlioglu, Deniz; Darken, Patrick; Biswas, Mousumi

doi:10.25384/SAGE.11448999.v1

Table_S1_28Aug2019.pdf (100.53 kB)

Table_S1_28Aug2019 – Supplemental material for Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β₂-agonist fixed-dose combinations in COPD

journal contribution

posted on 2019-12-24, 13:07 authored by Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, Mario Ouwens, Deniz Guranlioglu, Patrick Darken, Mousumi Biswas

Supplemental material, Table_S1_28Aug2019 for Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β₂-agonist fixed-dose combinations in COPD by Mohd Kashif Siddiqui, Pragya Shukla, Martin Jenkins, Mario Ouwens, Deniz Guranlioglu, Patrick Darken and Mousumi Biswas in Therapeutic Advances in Respiratory Disease